ArticleVacunas
Epidemic trends of COVID-19 in 10 countries compared with Turkey.
Article in Vacunas. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 12 citations in OpenAlex.
- Exploring pandemic preparedness through public perception and its impact on health service quality, attitudes, and healthcare image.Scientific reports · 2025Article
- Clinical and epidemiological risk factors associated with hospitalization and mortality rate of COVID-19 patients in Banja Luka County: A retrospective observational cohort study on 40,000 patients.Journal of family medicine and primary care · 2024Article
- Does the Public Health Security Capacity Provide Better Preparedness for Health Emergencies? A Cross-Sectional Analysis of 180 Countries During the COVID-19 Outbreak.Disaster medicine and public health preparedness · 2022Article
- Post-Coronavirus Disease-2019 (COVID-19): Toward a Severe Multi-Level Health Crisis?Medical sciences (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe outbreak rapidly spread to more than 200 countries and led to millions of confirmed cases as well as thousands of deaths worldwide. This makes a serious threat to the world in terms of public health. The present study aimed to compare the COVID-19 epidemic parameters in Turkey with the top ten countries that reported the highest number of confirmed cases worldwide on April 25, 2020. Plus, it might provide better insight into the efficacy of national interventions on the course of the disease by measuring the case-fatality rate.
methodsA detailed search of the Johns Hopkins University Center for Systems Science and Engineering official websites, and announcements were conducted between January 22 and April 25, 2020. COVID-19 related datasets for the distribution of the infection on each reported day were obtained.
resultsAlthough the growth rate sharply increased by more than 1.2% in the late January 2020, the cumulative number of cases remained below 1500 around the world. The epidemic growth curve in Turkey was very similar to the US and Italy during the period. The case-fatality rate in Turkey was 2.51%, which below the countries with the most cases, except Russia, and the recovery-death ratio appeared to be at a moderate level among these countries.
conclusionsSince there are no standard treatments for the disease, it is important to avoid infection or further spreading. Decision-makers should adopt a series of measures to mitigate the impact of the pandemic, using national surveillance systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.